Adult mouse models have been widely used to understand the mechanism behind disease progression in humans. The applicability of studies done in adult mouse models to neonatal diseases is limited. To better understand disease progression, host responses and long-term impact of interventions in neonates, a neonatal mouse model likely is a better fit. The sparse use of neonatal mouse models can in part be attributed to the technical difficulties of working with these small animals. A neonatal mouse model was developed to determine the effects of probiotic administration in early life and to specifically assess the ability to establish colonization in the newborn mouse intestinal tract. Specifically, to assess probiotic colonization in the neonatal mouse, Lactobacillus plantarum (LP) was delivered directly into the neonatal mouse gastrointestinal tract. To this end, LP was administered to mice by feeding through intra-esophageal (IE) gavage. A highly reproducible method was developed to standardize the process of IE gavage that allows an accurate administration of probiotic dosages while minimizing trauma, an aspect particularly important given the fragility of newborn mice. Limitations of this process include possibilities of esophageal irritation or damage and aspiration if gavaged incorrectly. This approach represents an improvement on current practices because IE gavage into the distal esophagus reduces the chances of aspiration. Following gavage, the colonization profile of the probiotic was traced using quantitative polymerase chain reaction (qPCR) of the extracted intestinal DNA with LP specific primers. Different litter settings and cage management techniques were used to assess the potential for colonization-spread. The protocol details the intricacies of IE neonatal mouse gavage and subsequent colonization quantification with LP.
Introduction
In infants, early probiotic exposure has been associated with immunomodulatory effects leading to reduced incidence of diseases like necrotizing enterocolitis, atopic dermatitis and sepsis 1, 2, 3, 4, 5 . However, the mechanism behind this immunomodulatory response is challenging to explore given the limitation to sampling in newborn human trials (i.e., sequential blood draws and biopsies). Neonatal mouse models can help study the mechanism of action involved in neonatal immune regulation associated with probiotic use and changes in the intestinal microbiota. Unfortunately, most mouse models for probiotics have largely focused on adult mice; however, the impact of probiotics is likely to be highest early in life, suggesting models specific for this age group will be useful 3, 6 . In addition, neonatal mouse models are better suited to study diseases and interventions intended for application in early life of human infants as they are expected to more closely mimic a developing immune and microbial system 7, 8, 9, 10 . The aim was to study the extent and patterns of probiotic colonization of neonatal mice with a focus on the mechanistic interaction between the host and its microbiome. Suitable descriptions of newborn models were not found in the literature, and thus a need for the development of robust and standardized method was addressed.
Established methods of oral administration of various compounds to newborn mice include maternal transfer of desired compounds through milk by treating the water source for pregnant dams 11 or using feeding needles to facilitate administration of desired compounds into the oropharynx 12 . These methods are useful for experiments that do not have precise dosage requirements and where the treatment is readily ingested by the recipient mouse. Probiotics are often administered in conjunction with a prebiotic such as galactooligosaccharide and fructooligosaccharide (FOS) that serve as a source of nutrition for probiotic bacteria; these additive compounds make the solution viscous and challenging to administer via the above-mentioned methodologies. Devising a method to administer precise amounts of probiotics and prebiotics to newborn mice starting as early as the first day of life (DOL) was necessary. In the process of developing the gavage technique, the possibility of colonization-spread (as observed in other probiotic studies between the treatment and the control arms the sternum). Mark the needle at the level of the snout to note the limit of insertion of the needle (Figure 1) . Observe the pup for health signs, which include regular breathing and pink coloration of the skin. 4. Dip the tip of the needle in the dipping solvent (5% dextrose saline or -the medium used to dissolve the probiotic and pre-biotic) to lubricate the external surfaces of the feeding needle. This facilitates the smooth entry of the needle into the esophagus of the mouse. 5. Lift the pup by the scruff or by gently holding the head and body between the thumb and index finger. Ensure the head, neck and body are held in a straight position. Do not hold the pup by the scruff for longer than 60 s as there is a risk of obstruction of the trachea leading to suffocation. Ensure the pup can breathe. Signs of scruffing too hard can include inability to breathe, significant gasping and the tongue extended out the mouth. Monitor the pup's color and breathing during the entire procedure. 6. Insert the bulb of the needle into the center of the mouth of the pup at a 45° angle to the plane of the torso until it reaches the back of the throat. 7. Gently change the angle of the needle by pivoting on the bulb of the needle and moving the syringe away from the gavaging person (towards the dorsal side of the pup) until it is parallel to the plane of the pup's vertebral column. Scruffing the pup helps keep the needle in place in the back of the throat, and also prevents the mouse from squirming. Make sure the ball of the needle does not advance or exert any pressure against the back of the throat during the angle change. 8. If the mouse attempts to swallow the needle, allow it to naturally slide downward and arrest the movement when the marking on the needle aligns with the snout. The syringe and needle are usually heavy enough to slide down the due to gravity. Support the weight of the needle at all times so the needle slides easily down the esophagus with no downward pressure from the person carrying out the gavage. 1. If the needle meets resistance in the back of the throat, withdraw the gavage needle slightly to dislodge the ball of the needle and reangle the needle inside the mouth towards left of the mouse (handler's right) slowly in small, 1 mm increments. The needle should start to slide easily down the esophagus. 2. If the needle stops before the marking on needle reaches the mouth, do not inject the solution. 3. Do not keep the needle inserted for more than 20 s. If this occurs, retract the needle slowly while keeping the syringe parallel to the torso and let the pup rest on the paper towel for 30 s to 1 min. Try gavaging again after lubricating the external surface of the needle with the solvent. NOTE: Anaesthesia is not used for the procedure as the mouse's response is necessary to gauge the success of gavage.
9. When the marking on the feeding needle is above the snout and aligned with the tip of the snout, do not let the needle move or advance any further. Slowly inject the desired volume of liquid. If the liquid is aspirated or observed to bubble through the nose, stop the injection immediately and slowly retract the needle. 1. Place the pup upright on the paper towel on the heating pad to aid in its recovery. Monitor closely for continued breathing problems or change in color of the pup which indicates aspiration. Euthanize pups that have aspirated immediately.
10. Once the gavage is complete, gently withdraw the feeding needle at the same angle it was inserted. Place the pup on the paper towel on the warmed heating pad. Wait 10 s for the pup to regain normal activity and breathing pattern. A healthy pink hue should appear over the pup's body and the dye should only be visible in the stomach compartment. Move it back to the cage with the other pups. NOTE: Gavaging blue food coloring is an excellent way to practice the procedure outlined above. If the gavage is successful, the stomach of the mouse will be visible as a blue hue.If the blue dye is found outside the stomach of the pup (neck, chest or axillary region), the animal should be humanely euthanized (in accordance with the animal care rules), as this indicates a rupture of the esophagus or aspiration.
Collection of intestional samples for colonization analysis
1. During subsequent monitoring or gavaging, collect fecal microbiome samples from the pups. NOTE: The pup frequently urinates and defecates when gavaged and this time can be used as an opportunity to collect the fecal samples for microbiome analysis. 2. For termination of experiments, collect the intestines from duodenum to rectum after euthanasia of the pups. Pin the pup to a surgical board and disinfect the skin with 70% ethanol. Cut away the skin into four quadrants without damaging the peritoneal layer using tools sterilized with 70% ethanol and a hot bead sterilization at 250 °C. 3. Use a different set of sterile tools to cut the peritoneum into four quadrants and move it away from the center in a way that the visceral organs are exposed. 4. Locate the stomach and use a clamp to pinch below the pyloric sphincter and at the end of rectum. Run the length of the intestine using a blunt tool or forceps to streamline the intestine and free it from the connective tissue and mesenteric tissue. Once the entire length of the intestine has been freed of connective tissue, cut at the clamped ends. 5. Mark the aluminum foil with the orientation of the intestine, wrap in a secure manner and freeze at -80 °C.
NOTE: The DNA extraction procedure can be carried out at this point without freezing. The blue dye was also seen to pass through the intestine over 24 h and collection of samples for colonization analysis is best when the intestines are collected at least 24 hours post the last gavage. Signals might be amplified before that timepoint by the non-adhered bacteria transiently passing through the gavage mixture.
DNA extraction from intestines for colonization analysis
NOTE: The DNA extraction is done using a commercial kit with optimizing modifications made to the protocol for the intestine DNA extraction. Ensure the heating apparatus is set to the desired temperature and the solutions that need alterations or pre-warming are prepared appropriately.
The procedure of IE gavage has been used in adult mice with relative ease. However, the upper gastrointestinal tract of a neonatal mouse is fragile and required calibrated movements of the gavage needle during the procedure. Repeated gavages could increase the chances of intraesophageal irritation, injury and failure or rejection by the dam due to the handling. Thus, two different gavaging schedules were tested and the intestinal colonization was quantified using DNA from whole intestine homogenates. Mice were gavaged from DOL 2 through DOL 8 with probiotic administered every day or every two days (Figure 3) . Each sample contained one technical replicate and every condition had at least two biological replicates. The pups gavaged every day with 7 doses had around 10 3 copies of LP whereas the pups gavaged every two days with 4 doses had around 10 5 copies. The consistency of results between the replicates add credit to the precision of technique. There was more LP detected in intestines of pups gavaged every two days in comparison with pups that were gavaged every day. Given this, subsequent experiments were set up with a gavage schedule of every other day as it also reduces the stress for the pups.
It is important to avoid intra-litter probiotic cross contamination when working with probiotics. The microbiome of littermates was expected to be similar as they share the same mother and nesting environment. This proves a problem for probiotic studies if the treatment and control conditions were present within the same litter as the probiotic organism has the potential to become a part of the microbiota ("colonization spread'). To determine if a probiotic will contaminate and colonize untreated littermates, half of a litter was gavaged as above and the intestines were collected for qPCR. Intestinal qPCR analysis of DOL 10 mice showed expected amplification of LP DNA in the gavaged mice but also, to a lesser degree in the non-gavaged littermates (Figure 4) . The intestines of the same DOL mice from an untreated cage showed no amplification or minimal amplification at cycles greater than 32. This provided evidence for the communal sharing of the microbiome within a litter in a cage. Thus, for experiments with probiotics the treatment groups should be separated by cages to control for variability through cross contamination. The use of foster dams can be considered if an experiment is to be set up within a litter setting, but confounding effects like diminished care from the foster dam and rejection should be evaluated and optimized for. When mice gavaged until DOL 8 were left untreated for six days and the intestinal DNA was analysed at DOL 14, approximately 10 copies of LP were found ( Figure 5) . Thus, the colonization of LP was found to be transient and the detectable population diminished over time. Step 
Discussion
The procedure of IE gavage was developed to safely administer a specific dose of a probiotic to neonatal mice. Small amounts of liquid are delivered to the upper gastrointestinal tract using a feeding needle to prevent aspiration while ensuring the delivery of the dosage in confidence. The intestines of the mice were collected for colonization analysis two and six days post gavage. The procedure for DNA extraction was modified to ensure high yield of the probiotic Gram-positive organism. The qPCR analysis of the DNA extracted two days post last gavage showed relatively higher colonization of LP in mice gavaged every two days in comparison to mice gavaged every day between DOL 2-8. There was also a decrease in the amount of LP over six days, showing this probiotic to be a transient organism in the intestines of the mouse. The results of these experiments establish the conditions to conduct research with high rigor in this age group. To observe the long-term effects of probiotics in neonatal mice, it was administered to neonatal mice on DOL 2; a similar starting time point to the human trial. Oropharyngeal feeding of neonatal mice is previously described in literature and has been carried out only after DOL 5-8 12,17 when the risk of aspiration is lower due to a well-developed swallowing mechanics. However, oropharyngeal feeding is not well suited for DOL 2 mice as higher rates of aspiration were observed in the pilot study (data not shown). The viscous nature of the probiotic and prebiotic solution added to the risk of aspiration. Following the IE gavaging procedure minimized the risk of aspiration in DOL 2 mice while delivering the desired volume directly to the upper gastrointestinal tract. The success of the procedure was first validated using food coloring infused probiotic gavage. The food coloring acts as a marker that is visible through the skin of the pup. No negative effects were observed in mice gavaged with food coloring, and it is recommended to validate the gavaging procedure in this manner prior to commencing large-scale experiments. The rapid resolution of the gasping reflex seen post gavage can also be used as an additional indicator for a successful gavage. Once the mouse is placed on the heating blanket post-gavage, the gasping reflex will subside and an increase in the breathing frequency will be observed within 20 seconds. The continuation of the gasping reflex for longer than 30 seconds indicates a failed gavage. Successful gavage also depends on appropriate insertion of the feeding needle with the bulb sitting right above the opening of the cardiac sphincter of the stomach. This can be facilitated by ensuring that the marking on the needle measuring the length between the xiphoid process and the tip of the snout, does not go past the snout of the mouse during gavage. This minimizes the chance of injury to the mouse. The frequency of gavage can have a significant impact on the experimental results. Frequent gavaging also can create more stress for the pups and the mother due to constant perturbation of the cage and the nest. The most optimal gavage schedule is when the gavages are the least frequent and over a shorter duration of time without losing the expected effect in the system. To ensure the safety and sterility of the procedure the gavage needle must be sterilized by washing and autoclaving in-between use. Washing rigorously on the outside using a scrub and the inside by forcing water through the needle using a syringe before autoclaving is necessary as any leftover particles can encrust on the needle during autoclaving and can interfere with the gavaging procedure.
Higher LP colonization was observed in pups that were gavaged every other day when compared to pups gavaged every day. This can be due to the reduced stress on pups gavaged every other day and potentially the probiotic getting more nutrients through the relatively more milk ingested by these pups. The dose dependency of probiotic treatment has been previously studied in mouse models 18, 19 and thus the administration of correct dosage is important. The probiotic solution prepared is plated before every gavage to get an accurate count of CFU administered. If the probiotic organism is anaerobic, it is important to see if there is difference in CFU when cultured aerobically or anaerobically. Since LP is a facultative anaerobe, it was cultured using both methods and no difference in CFU was observed.
The post gavage intestinal LP load analysis was done using qPCR and high-quality DNA samples. To minimize LP DNA contamination between the treatment and the control groups, different feeding needles, biosafety cabinets and surgical equipment were used to ensure highest quality samples. The accurate measurement of the probiotic in the intestine required an optimized DNA extraction method. Most efficient methods for the extraction of DNA from stool involves multiple bead beating steps 20, 21, 22 . This method was adopted for the extraction of intestinal bacteria using bead beating and observed diminished representation (<10 2 copies recovered) of LP in the whole intestine DNA extraction. As LP is a
Gram positive organism with a substantial amount of peptidoglycan in the cell wall, the protocol was optimized with a peptidoglycan dissolution step using lysozyme 23, 24 added to the enzymatic lysis buffer. This increased the representation of LP in the same intestinal sample by greater than two-fold. The lysozyme treatment ensures the dissolution of the outer layer while the bead beating step facilitates the lysis of the organism. Optimization of amount of tissue, the type of garnet bead and the duration of disruption using the beads is necessary for obtaining optimal DNA products to conduct the PCR analysis.
The positive impact of probiotics administered as prophylaxis or treatment in the pre-term and term neonates is evidenced in recent studies 25, 26, 27, 28 . The establishment of a proper neonatal mouse model for probiotics is warranted to unpack the protective effect of probiotics. This protocol outlined here represents a guide for researchers unfamiliar with neonatal mouse work using probiotics. Notwithstanding the issues with rodent microbiota while studying human health and disease, this method can be extended to research focused on understanding the changes of the microbiome due to probiotics. This model also provides a platform to study host-microbe interaction and immune responses over the course of different developmental stages.
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